Risk scores for predicting incident heart failure admission in patients with chronic coronary syndromes: Validation in a prospective, monocentric, long-term, cohort study

被引:0
作者
Lopez-Baizan, Josue [1 ]
Ruiz Ortiz, Martin [1 ,2 ]
Delgado Ortega, Monica [1 ,2 ]
Rodriguez Almodovar, Ana [1 ]
Esteban Martinez, Fatima [1 ]
Sanchez Fernandez, Carlos [1 ]
Sanchez Fernandez, Jose Javier [1 ]
Mateos de la Haba, Leticia [1 ]
Barreiro Mesa, Lucas [1 ]
Ogayar Luque, Cristina [1 ]
Romo Penas, Elias [1 ]
Lopez-Aguilera, Jose [1 ,2 ]
Carrasco Avalos, Francisco [1 ]
Castillo Dominguez, Juan Carlos [1 ,2 ]
Anguita Sanchez, Manuel [1 ,2 ]
Pan, Manuel [1 ,2 ]
Mesa Rubio, Dolores [1 ,2 ]
机构
[1] Reina Sofia Univ Hosp, Cardiol Dept, Ave Menendez Pidal S-N, Cordoba 14004, Spain
[2] IMIBIC, Maimonides Inst Biomed Res Cordoba, Cordoba, Spain
关键词
chronic coronary syndrome; heart failure; prognosis; risk scores; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; POPULATION; GUIDELINES; SURVIVAL;
D O I
10.1111/eci.13941
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Heart failure (HF) admission in chronic coronary syndrome (CCS) patients has a prognostic impact. Stratification schemes have been described for predicting this endpoint, but none of them has been externally validated. Objectives:Our aim was to develop point scores for predicting incident HF admission with data from previous studies, to perform an external validation in an independent prospective cohort and to compare their discriminative ability for this event. Methods:Independent predictive variables of HF admission in CCS patients without baseline HF were selected from four previous prospective studies (CARE, PEACE, CORONOR and CLARIFY), generating scores based on the relative magnitude of the coefficients of Cox of each variable. Finally, the scores were validated and compared in a monocentric prospective cohort. Results:The validation cohort included 1212 patients followed for up to 17 years, with 171 patients suffering at least one HF admission in the follow-up. Discriminative ability for predicting HF admission was statistically significant for all, and paired comparisons among them were all nonsignificant except for CORONOR score was superior to CLARIFY score (C-statistic 0.73, 95%CI 0.69-0.76 vs. 0.69, 95% CI 0.65-0.73; p = 0.03). Conclusion:All tested scores showed significant discriminative ability for predicting incident HF admission in this independent validation study. Their discriminative ability was similar, with significant differences only between the two scores with higher and lower performance.
引用
收藏
页数:11
相关论文
共 30 条
[1]  
[Anonymous], DAPA MI DAPAGLIFLOZI
[2]  
[Anonymous], **DATA OBJECT**
[3]   Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study [J].
Arnold, JMO ;
Yusuf, S ;
Young, J ;
Mathew, J ;
Johnstone, D ;
Avezum, A ;
Lonn, E ;
Pogue, J ;
Bosch, J .
CIRCULATION, 2003, 107 (09) :1284-1290
[4]   Predictors of Mortality in 6975 Patients With Chronic Heart Failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure Trial Proposal for a Nomogram [J].
Barlera, Simona ;
Tavazzi, Luigi ;
Franzosi, Maria Grazia ;
Marchioli, Roberto ;
Raimondi, Elena ;
Masson, Serge ;
Urso, Renato ;
Lucci, Donata ;
Nicolosi, Gian Luigi ;
Maggioni, Aldo P. ;
Tognoni, Gianni .
CIRCULATION-HEART FAILURE, 2013, 6 (01) :31-+
[5]   Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial [J].
Connolly, Stuart J. ;
Eikelboom, John W. ;
Bosch, Jackie ;
Dagenais, Gilles ;
Dyal, Leanne ;
Lanas, Fernando ;
Metsarinne, Kaj ;
O'Donnell, Martin ;
Dans, Anthony L. ;
Ha, Jong-Won ;
Parkhomenko, Alexandr N. ;
Avezum, Alvaro A. ;
Lonn, Eva ;
Liu Lisheng ;
Torp-Pedersen, Christian ;
Widimsky, Petr ;
Maggioni, Aldo P. ;
Felix, Camilo ;
Keltai, Katalin ;
Hori, Masatsugu ;
Yusoff, Khalid ;
Guzik, Tomasz J. ;
Bhatt, Deepak L. ;
Branch, Kelley R. H. ;
Bruns, Nancy Cook ;
Berkowitz, Scott D. ;
Anand, Sonia S. ;
Varigos, John D. ;
Fox, Keith A. A. ;
Yusuf, Salim .
LANCET, 2018, 391 (10117) :205-218
[6]   Guidelines on the management of stable angina pectoris: executive summary [J].
Fox, Kim ;
Angeles Alonso Garcia, Maria ;
Ardissino, Diego ;
Buszman, Pawel ;
Katowice ;
Camici, Paolo G. ;
Crea, Filippo ;
Daly, Caroline ;
De Backer, Guy ;
Ghent ;
Hjemdahl, Paul ;
Lopez-Sendon, Jose ;
Marco, Jean ;
Morais, Joao ;
Leiria ;
Pepper, John ;
Sechtem, Udo ;
Simoons, Maarten ;
Thygesen, Kristian ;
Priori, Silvia G. ;
Blanc, Jean-Jacques ;
Budaj, Andrzej ;
Camm, John ;
Dean, Veronica ;
Deckers, Jaap ;
Dickstei, Kenneth ;
Lekakis, John ;
McGregor, Keith ;
Metra, Marco ;
Morais, Joao ;
Osterspey, Ady ;
Tamargo, Juan ;
Zamorano, Jose L. ;
Andreotti, Felicita ;
Becher, Harald ;
Dietz, Rainer ;
Fraser, Alan ;
Hernandez Antolin, Rosa Ana ;
Huber, Kurt ;
Kremastinos, Dimitris T. ;
Maseri, Attilio ;
Nesser, Hans-Joachim ;
Pasierski, Tomasz ;
Sigwart, Ulrich ;
Tubaro, Marco ;
Weis, Michael .
EUROPEAN HEART JOURNAL, 2006, 27 (11) :1341-1381
[7]   ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina) [J].
Gibbons, RJ ;
Abrams, J ;
Chatterjee, K ;
Daley, J ;
Deedwania, PC ;
Douglas, JS ;
Ferguson, TB ;
Fihn, SD ;
Fraker, TD ;
Gardin, JM ;
O'Rourke, RA ;
Pasternak, RC ;
Williams, SV ;
Alpert, JS ;
Antman, EM ;
Hiratzka, LF ;
Fuster, V ;
Faxon, DP ;
Gregoratos, G ;
Jacobs, AK ;
Smith, SC .
CIRCULATION, 2003, 107 (01) :149-158
[8]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[9]   Temporal trends in event rates after Q-wave myocardial infarction - The framingham heart study [J].
Guidry, UC ;
Evans, JC ;
Larson, MG ;
Wilson, PWF ;
Murabito, JM ;
Levy, D .
CIRCULATION, 1999, 100 (20) :2054-2059
[10]  
Jaffe AS, 2013, CLIN BIOCHEM, V46, P1, DOI [10.1093/eurheartj/ehs184, 10.1016/j.clinbiochem.2012.10.036, 10.1161/CIR.0b013e31826e1058, 10.1016/j.jacc.2012.08.001, 10.1016/j.gheart.2018.08.004, 10.1016/j.gheart.2012.08.001, 10.5603/KP.2018.0203]